Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histones | 6 | 2019 | 2598 | 0.320 |
Why?
|
Lymph Nodes | 3 | 2023 | 3476 | 0.270 |
Why?
|
Enhancer Elements, Genetic | 2 | 2019 | 1340 | 0.210 |
Why?
|
Breast Neoplasms | 4 | 2023 | 20824 | 0.200 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2016 | 670 | 0.200 |
Why?
|
Lymphatic Metastasis | 3 | 2023 | 2924 | 0.190 |
Why?
|
Histone Code | 2 | 2019 | 163 | 0.180 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 516 | 0.160 |
Why?
|
CREB-Binding Protein | 1 | 2018 | 151 | 0.160 |
Why?
|
p300-CBP Transcription Factors | 1 | 2018 | 147 | 0.150 |
Why?
|
Cisplatin | 1 | 2024 | 1662 | 0.150 |
Why?
|
Histone Acetyltransferases | 1 | 2018 | 335 | 0.140 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 353 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2017 | 2943 | 0.140 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2019 | 520 | 0.140 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 182 | 0.130 |
Why?
|
Epigenomics | 2 | 2019 | 903 | 0.120 |
Why?
|
Immune Tolerance | 1 | 2023 | 2259 | 0.120 |
Why?
|
Methylation | 4 | 2016 | 1106 | 0.110 |
Why?
|
Interferon Type I | 1 | 2016 | 542 | 0.110 |
Why?
|
Azepines | 1 | 2015 | 334 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2016 | 1117 | 0.100 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1335 | 0.090 |
Why?
|
Epigenesis, Genetic | 3 | 2019 | 3646 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 2988 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2455 | 0.090 |
Why?
|
Quinazolines | 1 | 2015 | 1356 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2499 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2019 | 8432 | 0.070 |
Why?
|
Autophagy | 1 | 2015 | 1297 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2917 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4446 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2016 | 3024 | 0.060 |
Why?
|
HCT116 Cells | 2 | 2016 | 409 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2949 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3707 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2016 | 5023 | 0.060 |
Why?
|
Mice | 4 | 2024 | 81201 | 0.060 |
Why?
|
Apoptosis | 2 | 2016 | 9724 | 0.050 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7721 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 12073 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5856 | 0.050 |
Why?
|
Protein Binding | 3 | 2018 | 9384 | 0.050 |
Why?
|
Animals | 5 | 2024 | 168768 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 16690 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2018 | 4208 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2018 | 196 | 0.040 |
Why?
|
Tumor Escape | 1 | 2021 | 350 | 0.040 |
Why?
|
Signal Transduction | 2 | 2016 | 23404 | 0.040 |
Why?
|
I-kappa B Kinase | 1 | 2016 | 252 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2016 | 275 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 556 | 0.030 |
Why?
|
Humans | 12 | 2024 | 744366 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 365 | 0.030 |
Why?
|
Cytosol | 1 | 2016 | 901 | 0.030 |
Why?
|
Lymphocytes | 1 | 2021 | 2617 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3616 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2019 | 1783 | 0.030 |
Why?
|
HeLa Cells | 1 | 2018 | 3130 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 2015 | 563 | 0.030 |
Why?
|
Vesicular Transport Proteins | 1 | 2015 | 377 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2016 | 550 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21696 | 0.030 |
Why?
|
Ubiquitination | 1 | 2016 | 1012 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3590 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2016 | 1730 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2016 | 743 | 0.020 |
Why?
|
Lysine | 1 | 2016 | 1007 | 0.020 |
Why?
|
Oncogenes | 1 | 2017 | 1265 | 0.020 |
Why?
|
Cell Survival | 1 | 2021 | 5882 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2016 | 4320 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2016 | 1423 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4479 | 0.020 |
Why?
|
Female | 4 | 2023 | 380193 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1707 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1988 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4222 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1085 | 0.020 |
Why?
|
Mice, Nude | 1 | 2016 | 3689 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5218 | 0.020 |
Why?
|
Virus Replication | 1 | 2016 | 2535 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1376 | 0.020 |
Why?
|
Sirolimus | 1 | 2015 | 1565 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5867 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2016 | 2969 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6621 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2890 | 0.020 |
Why?
|
Proteomics | 1 | 2019 | 3638 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2933 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3505 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2016 | 2962 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3464 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4424 | 0.020 |
Why?
|
Escherichia coli | 1 | 2016 | 4217 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10183 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7798 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9445 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 16000 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19233 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29060 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7882 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18034 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12207 | 0.010 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_